INTRODUCTION
Since the early observations on antimetabolites a considerable literature has developed which is concerned chiefly with microorganisms and to a lesser degree with mammals. Comparatively little has been reported on the effect of antimetabolites on mammalian cells in tissue culture. However, the possibilities of this approach have been amply demonstrated in studies on various purines that might interfere with nucleic acid metabolism in tumor cells as compared with normal mammalian cells (1) .
Because of the importance of protein synthesis for the growth of cells, we have investigated the activity of certain materials which might interfere with protein metabolism. In particular we have studied the influence of amino acid analogs on the metabolism of tissue cultures of normal and neoplastic cells and tested their possible usefulness as antitumor agents. Antagonists of phenylalanine were chosen for the initial study because the metabolic pathways of this amino acid are more restricted. #-2-Thienyl-DL-alanine was selected because of the extensive background of microbiological data on its antagonism to phenylalanine (2) (3) (4) (5) (6) .
This paper reports the comparative toxicity of O-2-thienyl-DL-alanine as a phenylalanlue antagonist in tissue cultures of various mouse normal and tumor cells and data on the relative abilities of these cultures to utilize #-2-thienyl-DL-alanine for transamination.
The terms thienylalanine and thienylpyruvate will be used to refer to #-2-thienyl-DL-alanine and #-2-thienylpyruvate respectively, except when a comparison is made with compounds of similar structures.
Methods and Materials
Tissue Culture Texhniques.--Tissue culture studies were carried out with roller tube cultures of heart, and of sarcoma T-241 from C-57 black mice. Each tube contained six implants (approximately 2 to 4 mg. wet weight) in a clot made from 1 drop 20 per cent chick embryo extract and i drop chicken plasma. The cultures were fed 0.5 ml. of a medium which consisted of chick embryo extract, human placental cord serum, and a physiological salt solution (Simms' X-6 without phenol red) (7) in the proportions 2:3:7.5. 24 hours later the compounds were added in 0.5 ml. X-6. The cultures were examined microscopically 24 and 48 hours later and the toxic effects graded from 0 to 4+. Rounding up of the ceils, increase in granularity of the cytoplasm, and disintegration of cells were taken as evidences of a toxic effect. Preliminary experiments showed that over the toxicity range :t: to 4+, the effects of twofold differences in concentration of thienylalanine could be easily distinguished and that near the middle of the toxicity range the effects of 1.5-fold differences in concentration could be distinguished. All cultures were kept in a rotor run at 10 R.e.H. at 35-37°C.
When absorption spectra or paper strip chromatograms were desired on the culture fluids the method was modified since the serum and embryo extract interfered with these procedures. After planting, the cultures were washed with 3 to 4 changes of X-6, each wash being for 1/2 to 1 hour, until the plasma clot was clear and colorless. The cultures were then fed the compounds dissolved in 1 ml. of X-6. Under these conditions there is little or no outgrowth of cells from the implants, but the implants survive and function for a few days.
Paper Chromatography.--For paper chromatography the culture fluids were concentrated to one-fifth or one-tenth their original volumes and 0.005 or 0.0l ml. of concentrate used for each spot. Chromatograms were developed in n-butanol-water, collidine-water, and phenolwater systems, usually as ascending chromatograms. Schleicher and Schuell filter paper No. 597 was used.
Sources of Compounds.--phenylpyruvic acid and ~-2-thienylpyruvic acid were both synthesized by the method of Herbst and Shemin (8) . The/3-2-thienylpyruvi¢ acid was best purified by recrystallization from glacial acetic acid, from which it precipitated in brownish yellow crystals which had a melting point of 159-161°C. An elementary analysis gave: C 49.25, H 3.48; calculated, C 49.40, H 3.55. It gave an intense, transient purple color with ferric chloride and a neutral equivalent of 172 (theoretical 170). Caguiant and Caguiant (9) have synthesized B-2-thienylpyruvic acid by the condensation of 2-thienylacetonitrile with ethyl oxalate followed by acid hydrolysis of the resulting B-cyano-O-2-thienylpyruvate. Theyreported a melting point of 2450C. However, repeated preparations in this laboratory have given melting points in the range 159-167°C.
The O-2-thienyl-I~L-alanine used in this study was from three sources: commercial product (Nutritional Biochemical Corporation), a sample from Dr. Karl Dittmer of Florida State University, and one synthesized in this laboratory by the method of Dittmer et al. (I0) .
The commercial sample contained a small amount of a ninhydrin-positive compound which moved at almost the same rate as glutamic acid on paper chromatograms. It was therefore not used in experiments set up for paper chromatography or for quantitative work.
Dr. Karl Dittmer also supplied samples of O-3-thienyl-DL-alanine and O-2-furyl-DL-Manine. The pyridoxal phosphate was kindly supplied by Dr. W. W. Umbreit of Merck and Co., 6-methyl-DL-tryptophan by Dr. Karl Pfister of Merck and Co., 2-benzimidazole alanine by Eli Lilly and Co., and (5-uitro-o-phenetyl)-alanine and (p-nitrophenyl)-alanine by Parke, Davis and Co. All other compounds were purchased from commercial sources. Table I and Figs. I, 2 , 5, and 6, there is little difference in the toxicity of thienylalanine to heart fibroblasts and cells of sarcoma "1"-241. However, the macrophages which sometimes migrate out of sarcoma T-241 implants were more resistant to the action of thienylalanine. The toxicity of thienylalanine could be blocked by L-phenylalanine (Figs.  3 and 7) but not by D-phenylalanine.
RESULTS

Toxicity St~s.--As shown in
Inhibition ratios were determined by finding the amount of L-phenylalanine required for half-nullification of a 4+ toxicity. Thus our inhibition ratios are calculated in the same way as those given by Clark and Dittmer (11) . The inhibition ratios from six experiments with heart and sarcoma T-241 fell in the range: 12 to 24 moles thienylalanine per mole L-phenylalanine.
Effect of Other Compounds on the Toxicity of Thienylalanine.--Since tyrosine
and tryptophan have been shown to block the action of thienylalanine in some bacterial systems (3), we have tested a large number of amino acids and also some possible precursors of phenylalanine for their ability to prevent the Degree of toxicity
toxicity of thienylalanine. Table II shows the relative activity of a few of these compounds. We define the activity of a compound as the inhibition ratio for the compound divided by the inhibition ratio for L-phenylalanine multiplied by 100. This assigns an activity of 100 per cent to L-phenyialanine. L-Leucine, DL-isoleucine, DL-norleucine, DL-a-alanine, glycine, DL-threouine, L-cystine, L-cysteine, DL-aspartic acid, L-glutamic acid, DL-valine, L-histidine, L-arginine, L-lysine, glucose, acetoacetic acid, pyruvic acid, and a-ketoglutaric acid were inactive. Table H and Figs. 4 and 8 show one striking difference between the heart and sarcoma "1"-241 cultures. Phenylpyruvate blocked the toxicity of thienylalanine in heart cultures but not in sarcoma "1"-241 cultures. Early in the work, it was noticed that a faint reddish color appeared in the heart implants treated with thienylalanine but not in the sarcoma implants. This effect was markedly intensified in the heart cultures exposed to thienylalanine and phenylpyruvate; a pink-red color now appeared in the medium and the heart implants took on a deep red color. An absorption spectrum of the culture fluids showed a broad, flat peak at about 500 m#. No color appeared in the T-241 cultures; occasionally a trace of color was detected but this was not common and when it did occur, the sarcoma cultures contained considerable numbers of macrophages or stromal fibroblasts. No color ever appeared in the absence of thienylalanine. Furthermore the same color appeared in the heart cultures when pyruvate or a-ketoglutarate was substituted for phenylpyruvate although neither of these two a-keto acids had any activity in blocking thienylalanine.
Since phenylalanine was the only amino acid that blocked thienylalanine and since phenylpyruvate has been shown to substitute for phenylalanine in some bacteria (12) and in the diet of rats (13, 14) , it seemed likely that phenylpyruvate was converted to phenylalanine in the heart cultures. Whatever the * The sample of D-phenylalanine actually had an activity of 7 per cent in both heart and "1"-241 cultures. However, the optical rotation of the sample was that of a mixture of 90 per cent D-phenylalanine and 10 per cent L-phenylalanine. Therefore we believe that the activity is accounted for by the L-phenylalanine present in the sample. explanation, it must also account for the appearance of a common reaction product (the red-colored compound) when thienylalanine is incubated with a-ketoglutarate, pyruvate, or phenylpyruvate in heart cultures. Two metabolic reactions could reasonably account for these observations (a) a transamination between thienylalanine and the a-keto acid, or, (b) an oxidative deamination of thienylalanine and a simultaneous reductive amination of the a-keto acid. In both of these reactions thienylpyruvate would be one of the reaction products irrespective of the a-keto acid used; phenylalanine would be a product only if the a-keto acid were phenylpyruvate.
When thienylpyruvate was incubated with cultures of heart or sarcoma T-241, a red color appeared that was indistinguishable from that resulting from the incubation of thienylalanine and an a-keto acid with heart cultures. Furthermore, this same colored product appeared when thienylpyruvate was incubated in X-6 in the absence of any tissue, although color production was faster in the presence of tissue. Thus thienylpyruvate is an intermediate in the formation of the red-colored compound observed in our heart cultures.
Paper strip chromatography of concentrates of tissue culture media provided further evidence for reactions (a) or (b). Phenylalanine was found in culture fluids from heart cultures incubated for 48 hours with thienylalanine and phenylpyruvate but not in culture fluids from sarcoma T-241 cultures. Similarly, alanine was found in the fluids from heart cultures incubated with thienylalanine and pymvate but not in the fluids from T-241 cultures. Control cultures, to which no additions were made, to which only thienylalanine was added, and to which only the a-keto acid was added, were chromatographed simultaneously and the above mentioned amino acids were not found. By the same method, glutamic acid was shown to appear in culture fluids of heart cultures incubated with thienylalanine and a-ketoglutarate. The corresponding test with T-241 cultures could not give unequivocal results since significant amounts of glutamic acid appeared in the control cultures. However, no detectably greater amounts appeared than in the control cultures.
Thus cultures of mouse heart can convert thienylalanine and phenylpyruvate into phenylalanine and thienylpyruvate, the phenylalanine blocking the toxicity of unchanged thienylalanine and the thienylpyruvate undergoing a further reaction to form a red compound. This did not occur in cultures of sarcoma T-241.
Transamination.--Proof that the reaction involved is actually a transamination and not a reductive amination coupled with an oxidative deamination was obtained by (1) showing that pyridoxal phosphate, the coenzyme for known transaminases, activates the reaction, (2) eliminating the possibility of reductive amination by showing that ammonia does not further the reaction, and (3) showing that the stoichiometric balance of reactants and products is in accordance with transamination. A preparation of liver mitochondria was found to be very active in forming phenylalanine and thienylpyruvate from phenylpyruvate and thienylalanine. An enzyme preparation consisting of dialyzed mitochondria from mouse liver was therefore used for the quantitative studies.
Preparation of Enzyme.--Homogenates of 5 to 6 gm. mouse liver in 0.25 M sucrose (9 ml. per gm. liver) were prepared with a lucite homogenizer. An International Model PR-1 refrigerated centrifuge was used for the separation of mitochondrial fractions. The homogenate was centrifuged twice at 500 g for 10 minutes to remove nuclei and intact cells. The supematant was then centrifuged at 3000 g for 10 minutes. The pellet was resuspended in 0.25 M sucrose and again centrifuged at 3000 g for 10 minutes. The pellet was resuspended in 10 to 20 nil. 0.01 M phosphate buffer (pH 7.4) and dialyzed under nitrogen against 6 liters 0.01 M phosphate buffer (pH 7.4) for 16 hours. This was followed by another 8 hour dialysis against 2 to 5 liters fresh phosphate buffer. Visking tubing was used for the dialyses. Until immediately before use, all procedures with homogenates or fractions of homogenates were carried out in a cold room kept at 4°C.
Reaction Conditions.--Test tubes served as the reaction vessels. All reagents were dissolved in 0.05 ~ phosphate buffer at pH 7.4. The a-keto acids were first neutralized with sodium hydroxide. Additions to the reaction vessels consisted of 1 ml. enzyme, 40/~x¢ thienylalauine, 20 uM of the a-keto acid~ 20/~¢ ammonium chloride, and 20 w of the calcium salt of pyridoxal phosphate. When some of the reagents were omitted, an equivalent volume of phosphate buffer was added so that the total volume was always 3.1 ml. The tubes were incubated in the tissue culture rotor until a deep red color appeared in some of the tubes. The reaction was stopped by adding 0.5 ml. 1,62 N perchloric acid and centrifuging. Most of the red-colored compound was precipitated with the proteins. The precipitate was washed with two 2.5 ml. batches of 0.162 N perchloric acid. The original supernatant and the washes were combined in a 10 ml. volumetric flask, neutralized with sodium hydroxide, and diluted to the mark with distilled water. These solutions will be referred to as solutions A. To determine the amount of enzyme added to the vessels, 1 ml. of the enzyme preparation was precipitated with 5 ml. of cold 5 per cent trichloroacetic acid, washed with 5 per cent trichloroacetic acid, alcohol, alcohol-ether, and ether, and dried to constant weight.
DettrminaKon of Amino Adds.--To a 25 ml. volumetric flask were added 0.7 ml. solution A, 1 ml. 2 N HC1, and 4 ml. distilled water. This was extracted with four 15 ml. batches of ether that had been equilibrated with 2 N HC1, to remove any remaining red color and thienylpyruvate. The solutions were then boiled to drive off residual ether and diluted to the mark with distilled water. Thienylalanine was then determined in the Beckman Model DU spectrophotometer in terms of the absorption of the thiophene ring at 233 mu. Extraction of solutions containing known amounts of thienylalanine showed that about 11 per cent of the thienylalanine was extracted by this procedure. Corrections for this are made in the calculations. Total amino acids were determined on solutions A by the quantitative ninhydrin method of Moore and Stein (15) . The solutions were first alkalinized slightly and boiled to drive off all ammonia. Reaction vessels to which no substrates or to which an ¢x-keto acid but no thienylalanine had been added, gave ninhydrin readings less than 3 per cent of the experimental values. Recoveries of thienylalanine by ultraviolet absorption and by the ninhydrin method from reaction vessels to which no a-keto acid was added, agreed to within 2 per cent. Therefore, the ultraviolet readings were used to determine the amount of thienylalanine remaining in the reaction vessels. Subtraction of the ninhydrin equivalent of the thienylalanine from the ninhydrin readings gave the amount of other amino acids formed in the reaction vessels.
Determination of ~-Kelo Acids.----~-Ketoglutaric acid was determined by putting 0.02 ml.
spots of solutions A on the base line of a filter paper chromatogram and covering these with a large drop of a lukewarm (40°C.) solution of 1 rag. 2,4-dinitrophenylhydrazine per ml. 2 N HC1. Mter drying, another drop of this solution was put on the spots. The paper was then hung in a hood for 6 hours to drive off most of the HCh The chromatograms were developed in an n-butanol-water system. Known amounts of a-ketoglutarate were run on the same chromatograms. The 2,4-dinitrophenylhydrazones were eluted with 10 per cent sodium carbonate, alkalinized with sodium hydroxide, and measured in a Coleman Model 11 spectrophotometer at 432 m#. We were unable to determine phenylpyruvic acid. The 2,4-dinitrophenylhydrazones of phenylpyruvate and thienylpyruvate could not be completely separated on filter paper chromatograms or on small columns of super-eel by the method of LePage (16).
The results of such an experiment with phenylpyruvate as the c~-keto acid are shown in Table III . A similar experiment with a-ketoglutarate is given in Table IV .
Pyridoxal phosphate has a small but definite activating effect on the reaction. Ammonia has either no effect or a slight inhibiting effect. The stoichiometric balance of the reaction is in agreement with the hypothesis that the reaction is a transamination.
We hoped that the amount of the red-colored compound formed from thienylpyruvate could be used as a measure of the extent of transamination in our tissue cultures. When thienylpymvate is incubated in X-6 even in the absence of any tissue, the red color appears. Since thienylalanine alone does not give rise to color production, the formation of the red color in tissue cultures Dry weight of enzyme---0.9 mg. Incubated 17 hours at 37°C. * Per cent transamination is calculated from the amounts of thienylalanine disappearing, in terms of the L form of thienylalanine added. Dry weight of enzyme--6.7 rag. Incubated 5 hours at 37°C. incubated with thienylalanine and an a-keto acid is sufficient evidence that thienylpyruvate has been produced and therefore, from the results given above, evidence that some transamination has occurred. However, it was found that the rate of formation of the red-colored compound from thienylpymvate was higher in cultures of kidney, heart, liver, and brain in that order than in cultures of intestine, skeletal muscle, sarcoma T-241, sarcoma Ma 387, and Crocker mouse sarcoma 180. Taking these results into consideration, we can still use the rate of appearance of the red color to give us a rough idea of the relative rates of transamination of thienylalanine in tissue cultures.
TABLE IV Transamination between #-g-Thienyl-DL-alanine and a-Ketoglulacic Add
The results of such a determination are given in Tables V and VI. After planting, the cultures were washed with X-6 to remove all the color from the clots and then fed 1 ml. X-6 containing 1000 "r thienylalanine and 500 "r phenylpyruvate. After incubation for 24 and 48 hours, the cultures were arranged in the order of increasing depth of red color. The culture with the most red 
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color was arbitrarily assigned a grade of 4+ and unincubated X-6 was given a grade of zero; the rest of the cultures were given intermediate grades. The normal mouse tissues in Table V are all from C-57 black mice and the rat tissues in Table VI are from Sherman strain rats. All the normal tissues tested showed some transaminase activity but the rat tumors and the last five mouse sarcomas in Table V showed little or no activity. For heart and sarcoma T-241, these conclusions are completely in agreement with the toxicity studies.
The Nature of the Red-Colored Compound Formed from Thienylpyruvate.--
Incubation of thienylpyruvate with heart homogenates results in color production under aerobic and anaerobic conditions. In the absence of tissue, the reaction occurs only under aerobic conditions. The reaction is not affected by the addition of magnesium, manganous, cobaltous, cupric, ferrous, or ferric salts and the color of the product is not changed by these ions, however, addition of cyanide markedly slows down color production. The reaction occurs primarily at neutral and alkaline pH. The depth of color after 3 hours' incubation at 37°C. Table VII .
The red product is very insoluble below pH 4. It can be almost quantitatively precipitated by saturating a solution of it with ammonium sulfate and acidifying to pH 3-4. A small sample of this colored compound has been obtained in a fairly pure state by repeated precipitation and washing at pH 3-4. A molecular weight determination, by the depression of the melting point of camphor, gave a value of 310 -4-30. Elementary analysis: C 52.10, H 3.17, S 26.35. This analysis agrees fairly well with the empirical formulas CuHsS203 and Cld-InS30~. The structure of the compound has not yet been determined but a study of the reaction is in progress and will be reported in the future.
Phenyllactate as a Precursor of Phenylalanine.--As shown in Table II, phenyllactic acid could not block the toxicity of thienylalanine in cultures of mouse heart or sarcoma T-241. This was an unexpected result in view of the findings with phenylpyruvate, since both phenylpyruvate and phenyllactate can replace phenylalanine in the diet of the rat (13, 14) . The possibility remained that the ability to convert phenyllactate to phenylaianine is restricted to only a few organs or that the mouse cannot utilize phenyllactate. To test the former, tissue cultures of heart, liver, and kidney were fed 2000 "r of thienylalanine and various amounts of phenyllactate. To insure that toxicity gradings were always made on the same cell type, two implants of heart were put into the kidney and liver cultures; all toxicity gradings were made on the fibroblasts migrating out of the heart implants. Phenyliactate was 15 to 20 per cent as effective as L-phenylalanine in blocking the toxicity of thienylalanine in cultures of liver and kidney and was inactive in the heart cultures. At the same time, the red color appeared in the media of the liver and kidney cultures but not in the heart cultures. In other experiments in which mixed cultures were not used, heart, brain, skeletal muscle, and small intestine could not utilize phenyllactate whereas liver and kidney could, as judged by the ability of these tissues to form the red-colored compound when incubated with thienylalanine and phenyllactate. Thus the formation of phenylalanine from phenyllactate probably involves a conversion to phenylpyruvate which is restricted to only a few organs in the body, followed by transamination of phenylpyruvate to phenylaianine.
Other Phenylalanine Antagonists and Substituted Alanines.--Much of our work on O-2-thienyl-Dz-alanine has been repeated on /3-3-thienyl-Dz-alanine and /3-2-furyl-I)l.-alanine. The former is slightly more toxic and the latter less toxic than/3-2-thienyl-Dz-alanine. Again, there was little selective damage to sarcoma T-241. As with/3-2-thienyl-DL-alanine, the toxicity of these compounds could be blocked by phenylalanine in both heart and T-241 cultures but by phenylpyruvate only in heart cultures. In the heart cultures, /3-2-furyl-DI.-alanine gives a faint orange color when incubated with an a-keto acid but the/3-3-thienyl-Dz-alanine gives no color.
A number of other substituted alanines have also given colored products when incubated with a-ketoglutarate in heart cultures. Tryptophan, (5-nitro-ophenetyl)-alanine, (p-nitrophenyl)-alanine, 2-benzimidazole alanine, and 6-methyltryptophan all gave small amounts of color varying from tan to brown in hue. Presumably the reactions involved are transamination followed by a further reaction of the a-keto acids corresponding to the above amino acids to form a colored compound as in the case of thienylalanine. DISCUSSION ~-2-Thienyl-DL-alanine is specifically an L-phenylalanine antagonist for the mammalian cells we have studied. The toxicity of thienylalanine was blocked by L-phenylalanine but not by any of the nineteen other natural amino acids that were tested. These results are in sharp contrast to those with microorganisms. Dittmer et al. (3) have shown that tyrosine and tryptophan have some activity in preventing the growth inhibition of E. coli by thienylalanine and that leucine, isoleucine, and tryptophan have some activity with S. cerevisiae. As more antiamino acids are tested, it will be interesting to see whether this difference continues to hold true.
The mode of action of thienylalanine has not been determined but there is good reason to believe that the toxic effects seen in tissue culture are due to interference with protein synthesis. Obviously, the toxicity of thienylalanine in the tissue cultures is not related to its ability to act as a substrate in transamination except of course when we link the two systems by introducing phenylpyruvate. Thus in this somewhat simplified living system, a single compound acts as an antimetabolite in one set of reactions and as a substrate for another. This type of result should caution us about accepting overly simple interpretations of the effect of antimetabolites in living systems. It suggests the possibility that not only may an antimetabolite inhibit some reactions and serve as a substrate for others but the products of those reactions in which the antimetabolite is acting as a substrate may then act as antimetabolites for other reactions. A complete discussion of all these possibilities has been given by Woolley (17) .
Our results have some important implications for the search for chemotherapeutic agents for the treatment of cancer. It has often been suggested that if one can find major differences in the metabolism of normal and neoplastic cells, chemotherapeutic agents may be designed to damage selectively the tumor cells. From the viewpoint of therapeutics it would be important that this difference exist between the tumor and all the vital organs of the body but a large difference between the tumor cell and its normal homolog would not always be necessary. For the last five mouse sarcomas in Table V and  the rat tumors in Table VI , we have such a difference and an example of the use of this difference to kill the cells of sarcoma T-241 in tissue culture, under conditions that do not damage the cells from heart implants. We would not expect such a clear difference in vivo. From the chromatographic results, we know that the phenylalanine resulting from transamination of thienylalanine and phenylpyruvate does not remain in the heart cells, but diffuses out into the extracellular fluid. In vivo then, we would expect some spillage of the phenylalanine over into the tumor. In preliminary in vivo experiments with sarcoma T-241 we have observed some inhibition of the tumor but no such marked effect as in tissue culture. Nonetheless, the results in tissue culture serve as a laboratory model of the type of results we may hope to obtain in the animal from a comparative study of the metabolic pathways of normal and neoplastic cells.
The finding that thienylalanine and a number of other substituted alanines can enter transamination reactions again raises the question of the scope of transamination. In their early work, Braunstein and Kritzmann (18) suggested that most amino acids could undergo transamination. However only two transaminases, glutamic-oxalacetic transaminase and glutamic-pyruvic transaminase, have been obtained in a high degree of purity, and these have a high substrate specificity. Cohen (19, 20) then emphasized that in pigeon breast muscle and pig heart muscle transamination was limited primarily to dibasic a-amino and dibasic a-keto acids, although he also showed that in kidney and liver many of the monobasic amino acids could undergo transamination but at a much slower rate. Recently, work with homogenates and fractions of homogenates by Hird and Rowsell (21) , Rowsell (22) , and Cammarata and Cohen (23) has again emphasized the importance of transamination involving monobasic amino acids. Our results lend further support to this view.
Finally we should like to point up some of the advantages of combining tissue culture and antimetabolite studies. Not only is it possible to work out metabolic pathways but one can also study the organ distribution of a metabolic function as we have done for the conversion of phenyllactate into phenylalanine.
SUMMARY
In tissue cultures of C-57 black mouse heart and sarcoma T-241, ~-2-thienyl-DL-alanine acts specifically as a phenylalanine antagonist.
Heart cultures can transaminate between ~-2-thienyl-DL-alanine and phenylpyruvate to form L-phenylalani~e and thus block the toxic action of the remaining B-2-thienyl-DL-alanine, whereas sarcoma T-241 cultures cannot.
Of eleven mouse tumors and four rat tumors tested for their ability to perform this reaction, nine tumors had little or no activity.
The/3-2-thienylpyruvic acid resulting from transamination further reacts to form a red compound the exact structure of which is not yet known. 
